| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 54 | 38.792 | 82.910 |
| Total Income - EUR | - | - | - | - | - | - | - | 10.981 | 80.304 | 90.247 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 23.837 | 113.707 | 104.591 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -12.857 | -33.403 | -14.343 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -12.857 | -33.791 | -16.838 |
| Employees | - | - | - | - | - | - | - | 4 | 5 | 4 |
Check the financial reports for the company - Sinbio Lab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 51.602 | 53.403 | 57.274 |
| Current Assets | - | - | - | - | - | - | - | 38.330 | 7.016 | 12.500 |
| Inventories | - | - | - | - | - | - | - | 7.099 | 3.403 | 6.639 |
| Receivables | - | - | - | - | - | - | - | 24.191 | 3.266 | 4.516 |
| Cash | - | - | - | - | - | - | - | 7.039 | 348 | 1.345 |
| Shareholders Funds | - | - | - | - | - | - | - | -12.817 | -46.569 | -63.147 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 16.909 | 62.921 | 96.438 |
| Income in Advance | - | - | - | - | - | - | - | 85.839 | 44.067 | 36.484 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8691 - 8691" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Sinbio Lab S.r.l.